ISIS Financial Facts
Income tax expense: 0Diluted net loss (in dollars per share): 0.06
See Full Income Statement
Short-term investments: 603.57M
Total current assets: 730.33M
See Full Balance Sheet
Isis Pharmaceuticals, Inc. (ISIS) Earnings
|
Expand Research on ISIS
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +296.6% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +4.5% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/9/15  |
 |
Q315 | -$0.30 | -$0.31 | +$0.01 | $49.1M | $52.93M | N/A |  | | Details |
| 8/4/15 |
|
Q215 | $0.29 | $0.29 | $0.00 | $120.4M | $114.93M | N/A | | | Details |
| 5/5/15 |
|
Q115 | -$0.14 | -$0.21 | +$0.07 | $62.6M | $52.74M | N/A | | | Details |
| 2/27/15 |
|
Q414 | $0.25 | $0.02 | +$0.23 | $84.9M | $74.58M | N/A | | | Details |
| 11/7/14 | Q314 | -$0.23 | -$0.20 | -$0.03 | $44.1M | $45.8M | N/A | | | Details | |
| 8/4/14 |
|
Q214 | -$0.10 | -$0.12 | +$0.02 | $57.1M | $45.6M | N/A | | | Details |
| 5/6/14 |
|
Q114 | -$0.27 | -$0.23 | -$0.04 | $28.2M | $35.12M | N/A | | | Details |
| 2/28/14 |
|
Q413 | -$0.21 | -$0.17 | -$0.04 | $42.2M | $34.2M | N/A | | | Details |
